QS Investors’s GenMark Diagnostics, Inc GNMK Stock Holding History

QS Investors’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-44,400	Closed	-$1.06M	–	1273
2021 Q1	$1.06M	Sell	44,400 -500	-1%	-$9.29K	0.01%	521
2020 Q4	$656K	Hold	44,900	–	–	0.01%	657
2020 Q3	$638K	Sell	44,900 -190,000	-81%	-$2.9M	0.01%	592
2020 Q2	$3.46M	Sell	234,900 -37,700	-14%	-$383K	0.05%	305
2020 Q1	$1.12M	Hold	272,600	–	–	0.02%	633
2019 Q4	$1.29M	Hold	272,600	–	–	0.01%	712
2019 Q3	$1.65M	Buy	+272,600	New	+$1.7M	0.02%	627

QS Investors's GNMK Position: Q2 2021 in Review

QS Investors sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 44,400 shares — an estimated $1.06M sold.

QS Investors first reported a position in GNMK in Q3 2019 and held it in 7 quarters. The position peaked at $3.46M in Q2 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

QS Investors reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
QS Investors sold 44,400 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.06M.
QS Investors first reported a position in GenMark Diagnostics, Inc in Q3 2019 and held it in 7 quarters.
QS Investors's GenMark Diagnostics, Inc position peaked at $3.46M in Q2 2020.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.